Burden of medically attended influenza infection and cases averted by vaccination – United States, 2013/14 through 2015/16 influenza seasons

Vaccine

Volumn 36, Issue 4, 2018, Pages 467-472

  Jackson, Michael L ^a   Phillips, C Hallie ^a   Benoit, Joyce ^a   Jackson, Lisa A ^a   Gaglani, Manjusha ^b   Murthy, Kempapura ^b   McLean, Huong Q ^c   Belongia, Edward A ^c   Malosh, Ryan ^d   Zimmerman, Richard ^e   Flannery, Brendan ^f  

^a KAISER PERMANENTE   (United States)

^b TEXAS A M COLLEGE OF MEDICINE   (United States)

^c MARSHFIELD CLINIC   (United States)

^d UNIVERSITY OF MICHIGAN   (United States)

^e UNIVERSITY OF PITTSBURGH   (United States)

^f CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

Author keywords

Incidence; Influenza, human; Influenza, vaccines

Indexed keywords

INFLUENZA VACCINE;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CHILD; CONTROLLED STUDY; DISEASE BURDEN; DISEASE SURVEILLANCE; DRUG EFFICACY; EPIDEMIC; HUMAN; INCIDENCE; INFANT; INFLUENZA; INFLUENZA VACCINATION; MAJOR CLINICAL STUDY; OUTPATIENT CARE; PRIORITY JOURNAL; TEXAS; UNITED STATES; VACCINATION COVERAGE; WASHINGTON; WISCONSIN; AMBULATORY CARE; COST OF ILLNESS; FEMALE; HEALTH SURVEY; HISTORY; HOSPITALIZATION; IMMUNOLOGY; MALE; MIDDLE AGED; NEWBORN; OUTCOME ASSESSMENT; PRESCHOOL CHILD; PREVENTIVE HEALTH SERVICE; SEASON; VACCINATION; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AMBULATORY CARE; CHILD; CHILD, PRESCHOOL; COST OF ILLNESS; FEMALE; HISTORY, 21ST CENTURY; HOSPITALIZATION; HUMANS; IMMUNIZATION PROGRAMS; INCIDENCE; INFANT; INFANT, NEWBORN; INFLUENZA VACCINES; INFLUENZA, HUMAN; MALE; MIDDLE AGED; OUTCOME ASSESSMENT (HEALTH CARE); POPULATION SURVEILLANCE; SEASONS; UNITED STATES; VACCINATION; VACCINATION COVERAGE; YOUNG ADULT;

EID: 85053063761     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2017.12.014     Document Type: Article

References (25)

1. Grohskopf, L.A., Sokolow, L.Z., Olsen, S.J., Bresee, J.S., Broder, K.R., Karron, R.A., Prevention and control of influenza with vaccines: recommendations of the advisory committee on immunization practices, united states, 2015–16 influenza season. MMWR Morb Mortal Wkly Rep 64 (2015), 818–825.
2. Carias, C., Reed, C., Kim, I.K., Foppa, I.M., Biggerstaff, M., Meltzer, M.I., et al. Net costs due to seasonal influenza vaccination – United States, 2005–2009. PLoS One, 10, 2015, e0132922.
3. Belongia, E.A., Kieke, B.A., Donahue, J.G., Greenlee, R.T., Balish, A., Foust, A., et al. Effectiveness of inactivated influenza vaccines varied substantially with antigenic match from the 2004–2005 season to the 2006–2007 season. J Infect Dis 199 (2009), 159–167.
4. Skowronski, D.M., Chambers, C., Sabaiduc, S., De Serres, G., Winter, A.L., Dickinson, J.A., et al. A perfect storm: impact of genomic variation and serial vaccination on low influenza vaccine effectiveness during the 2014–2015 season. Clin Infect Dis, 2016.
5. Zimmerman, R.K., Nowalk, M.P., Chung, J., Jackson, M.L., Jackson, L.A., Petrie, J.G., et al. 2014–2015 influenza vaccine effectiveness in the united states by vaccine type. Clin Infect Dis, 2016.
6. Ohmit, S.E., Thompson, M.G., Petrie, J.G., Thaker, S.N., Jackson, M.L., Belongia, E.A., et al. Influenza vaccine effectiveness in the 2011–2012 season: protection against each circulating virus and the effect of prior vaccination on estimates. Clin Infect Dis 58 (2013), 319–327.
7. Pebody, R., Warburton, F., Ellis, J., Andrews, N., Potts, A., Cottrell, S., et al. Effectiveness of seasonal influenza vaccine for adults and children in preventing laboratory-confirmed influenza in primary care in the United Kingdom: 2015/16 end-of-season results. Euro Surveill, 21, 2016.
8. Skowronski, D.M., Janjua, N.Z., Sabaiduc, S., De Serres, G., Winter, A.L., Gubbay, J.B., et al. Influenza A/Subtype and B/lineage effectiveness estimates for the 2011–2012 trivalent vaccine: cross-season and cross-lineage protection with unchanged vaccine. J Infect Dis, 2014.
9. Kissling, E., Valenciano, M., Early estimates of seasonal influenza vaccine effectiveness in Europe among target groups for vaccination: results from the I-MOVE multicentre case-control study, 2011/12. Euro Surveill, 17, 2012.
10. Gaglani, M., Pruszynski, J., Murthy, K., Clipper, L., Robertson, A., Reis, M., et al. Influenza vaccine effectiveness against 2009 pandemic influenza A(H1N1) virus differed by vaccine type during 2013–2014 in the United States. J Infect Dis. 213 (2016), 1546–1556.
11. Barker, W.H., Mullooly, J.P., Underestimation of the role of pneumonia and influenza in causing excess mortality. Am J Public Health 71 (1981), 643–645.
12. Jackson, M.L., Jackson, L.A., Kieke, B., McClure, D., Gaglani, M., Murthy, K., et al. Incidence of medically attended influenza infection and cases averted by vaccination, 2011/2012 and 2012/2013 influenza seasons. Vaccine 33 (2015), 5181–5187.
13. McLean, H.Q., Thompson, M.G., Sundaram, M.E., Kieke, B.A., Gaglani, M., Murthy, K., et al. Influenza vaccine effectiveness in the United States during 2012–2013: variable protection by age and virus type. J Infect Dis 211 (2015), 1529–1540.
14. Kieke, A.L., Kieke, B.A. Jr., Kopitzke, S.L., McClure, D.L., Belongia, E.A., VanWormer, J.J., et al. Validation of health event capture in the marshfield epidemiologic study area. Clin Med Res 13 (2015), 103–111.
15. Jackson, M.L., Chung, J.R., Jackson, L.A., Phillips, C.H., Benoit, J., Monto, A.S., et al. Influenza vaccine effectiveness in the United States during the 2015–2016 season. N Engl J Med. 377 (2017), 534–543.
16. Rolfes, M.A., Foppa, I.M., Garg, S., Flannery, B., Brammer, L., Singleton, J.A., et al. Estimated influenza illnesses, medical visits, hospitalizations, and deaths averted by vaccination in the United States. 2016, CDC.
17. Gerdil, C., The annual production cycle for influenza vaccine. Vaccine 21 (2003), 1776–1779.
18. Steinbruck, L., Klingen, T.R., McHardy, A.C., Computational prediction of vaccine strains for human influenza A (H3N2) viruses. J Virol. 88 (2014), 12123–12132.
19. Kostova, D., Reed, C., Finelli, L., Cheng, P.Y., Gargiullo, P.M., Shay, D.K., et al. Influenza illness and hospitalizations averted by influenza vaccination in the United States, 2005–2011. PLoS One, 8, 2013, e66312.
20. Centers for Disease C, Prevention. Estimated influenza illnesses and hospitalizations averted by influenza vaccination – United States, 2012-13 influenza season. MMWR Morb Mortal Wkly Rep. 2013;62: p. 997–1000.
21. Reed, C., Kim, I.K., Singleton, J.A., Chaves, S.S., Flannery, B., Finelli, L., et al. Estimated influenza illnesses and hospitalizations averted by vaccination–United States, 2013–14 influenza season. MMWR Morb Mortal Wkly Rep 63 (2014), 1151–1154.
22. Greenlee, R.T., Measuring disease frequency in the marshfield epidemiologic study area (MESA). Clin Med Res 1 (2003), 273–280.
23. Saunders, K., Davis, R., Stergachis, A., Group Health Cooperative. Strom, B., (eds.) Pharmacoepidemiology, 4th ed., 2005, Wiley, New York.
24. Ebell, M.H., Afonso, A., A systematic review of clinical decision rules for the diagnosis of influenza. Ann Fam Med 9 (2011), 69–77.
25. Osterholm, M.T., Kelley, N.S., Sommer, A., Belongia, E.A., Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis. Lancet Infect Dis, 2011.